Overview
Meru Health is a digital clinic for depression, anxiety, and burnout that combines therapist-led coaching, biofeedback wearables, and an app-based program. Their 12-week program is clinically validated and covered by major US insurers.
Meru Health is a digital mental health clinic specializing in the treatment of depression, anxiety, and burnout through an integrated technology platform. The company combines therapist-led coaching with biofeedback wearables and a mobile app to deliver a comprehensive 12-week treatment program. Their approach leverages real-time physiological data from wearables to inform personalized interventions and track patient progress throughout the program. By merging human expertise with quantifiable biometric feedback, Meru Health bridges the gap between traditional therapy and data-driven digital health solutions.
The company has achieved significant commercial traction with its clinically validated program covered by major US insurers, reducing barriers to patient access and reimbursement. Meru Health raised $38 million in Series B funding, positioning itself as a well-capitalized player in the competitive digital mental health landscape. Their clinical validation distinguishes them in a crowded market and demonstrates measurable clinical outcomes that appeal to both payers and healthcare systems. Based in San Francisco, the company is strategically located in the heart of the neurotechnology and digital health innovation ecosystem.
Meru Health represents an important inflection point for the neurotech industry by proving that wearable biofeedback devices can deliver clinical value when integrated into structured mental health interventions. Their model demonstrates the viability of combining objective physiological measurements with therapeutic coaching, establishing a blueprint for next-generation digital therapeutics. As insurance coverage expands and outcomes data accumulates, Meru Health's approach validates the broader premise that neurotechnology can improve mental health outcomes at scale while addressing the persistent shortage of mental health providers.
More in Mental Health Tech
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 ยท Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 ยท Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 ยท Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 ยท Industry
Company details
Category
๐ Mental Health Tech
Location
San Francisco, USA
Funding
Series B ยท $38M
Website
meruhealth.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ